Graduate Nanotechnology Program, The American University in Cairo (AUC), AUC Avenue, P.O. Box 74, New Cairo, 11835, Egypt.
Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, MI, 48105, USA.
Sci Rep. 2023 Jan 17;13(1):886. doi: 10.1038/s41598-022-27152-4.
Wound healing is a well-organized dynamic process involving coordinated consecutive phases: homeostasis, inflammation, proliferation and resolution. Fibroblasts play major roles in skin wound healing such as in wound contraction and release of growth factors which are of importance in angiogenesis and tissue remodeling. Abnormal fibroblast phenotypes have been identified in patients with chronic wounds. In this work, we analyzed scRNA-seq datasets of normal and wounded skin from mice at day 4 post-wound to investigate fibroblast heterogeneity during the proliferative phase of wound healing. Compositional analysis revealed a specific subset of fibroblast (cluster 3) that primarily increased in wounded skin (14%) compared to normal skin (3.9%). This subset was characterized by a gene signature marked by the plasma membrane proteins Sfrp2 + Sfrp4 + Sfrp1 + and the transcription factors Ebf1 + Prrx1 + Maged1 + . Differential gene expression and enrichment analysis identified epithelial to mesenchymal transition (EMT) and angiogenesis to be upregulated in the emerging subset of fibroblasts of the wounded skin. Using two other datasets for murine wounded skin confirmed the increase in cluster 3-like fibroblasts at days 2, 7 and 14 post-wounding with a peak at day 7. By performing a similarity check between the differential gene expression profile between wounded and normal skin for this emerging fibroblast subset with drug signature from the ConnectivityMap database, we identified drugs capable of mimicking the observed gene expression change in fibroblasts during wound healing. TTNPB, verteprofin and nicotinic acid were identified as candidate drugs capable of inducing fibroblast gene expression profile necessary for wound healing. On the other hand, methocarbamol, ifosfamide and penbutolol were recognized to antagonize the identified fibroblast differential expression profile during wound healing which might cause delay in wound healing. Taken together, analysis of murine transcriptomic skin wound healing datasets suggested a subset of fibroblasts capable of inducing EMT and further inferred drugs that might be tested as potential candidates to induce wound closure.
伤口愈合是一个组织有序的动态过程,涉及协调的连续阶段:稳态、炎症、增殖和解决。成纤维细胞在皮肤伤口愈合中发挥重要作用,如伤口收缩和释放生长因子,这些因子对血管生成和组织重塑很重要。在慢性伤口患者中已经鉴定出异常的成纤维细胞表型。在这项工作中,我们分析了小鼠伤口后第 4 天正常和受伤皮肤的 scRNA-seq 数据集,以研究增殖期伤口愈合过程中成纤维细胞的异质性。组成分析显示,在受伤皮肤中(14%)比正常皮肤(3.9%)主要增加的特定成纤维细胞亚群(簇 3)。该亚群的特征是基因特征标记为质膜蛋白 Sfrp2+Sfrp4+Sfrp1+和转录因子 Ebf1+Prrx1+Maged1+。差异基因表达和富集分析确定上皮到间充质转化(EMT)和血管生成在受伤皮肤中新出现的成纤维细胞亚群中上调。使用另外两个用于小鼠受伤皮肤的数据集证实,在受伤后第 2、7 和 14 天,簇 3 样成纤维细胞增加,在第 7 天达到峰值。通过在连接图谱数据库的药物特征与受伤和正常皮肤之间的新兴成纤维细胞亚群的差异基因表达谱之间进行相似性检查,我们确定了能够模拟伤口愈合过程中成纤维细胞观察到的基因表达变化的药物。TTNPB、verteprofin 和烟酸被鉴定为能够诱导伤口愈合过程中成纤维细胞基因表达谱所必需的候选药物。另一方面,methocarbamol、ifosfamide 和 penbutolol 被识别为拮抗伤口愈合过程中鉴定的成纤维细胞差异表达谱的药物,这可能导致伤口愈合延迟。总之,对小鼠转录组皮肤伤口愈合数据集的分析表明,存在能够诱导 EMT 的成纤维细胞亚群,并进一步推断出可能作为潜在候选药物来诱导伤口闭合的药物。